Advisortrust Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Advisortrust Partners's GILD Position: Q3 2026 in Review
Advisortrust Partners reduced its Gilead Sciences (GILD) stake by 0.56% in Q3 2026, selling an estimated $2.24K and leaving 2,829 shares worth $422K. The position accounts for 0.13% of the portfolio, ranked #126.
Advisortrust Partners first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Advisortrust Partners held 2,829 shares of Gilead Sciences worth $422K as of Q3 2026.
- Advisortrust Partners sold 16 Gilead Sciences shares in Q3 2026, an estimated $2.24K.
- Gilead Sciences made up 0.13% of Advisortrust Partners's portfolio in Q3 2026, its #126 holding.
- Advisortrust Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.